Superior anti-tumor activity of ADH-1 in vivo compared to erlotinib (Tarceva®) in lung cancer cell lines

被引：0
|
作者：
Chan, Daniel
Gupta, Mukur
Zheng, Di
Zhang, Zhiyong
Sui, Xiaomei
Peters, William
Bunn, Paul
机构：
[1] Univ Colorado, Ctr Canc, Aurora, CO USA
[2] Adherex Technol Inc, Durham, NC USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-32
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Anti-tumor activity of ADH-1 in vitro and in vivo in combination with erlotinib (Tarceva®) in lung cancer cell lines
    Chan, Daniel C.
    Gupta, Mukur
    Zhang Zhiyong
    Zheng Di
    Sui Xiaomei
    Peters, Williams P.
    Bunn, Paul A., Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S795 - S795
  • [2] Anti-tumor activity of ADH-1 in vitro and in vivo in combination with paclitaxel in ovarian cancer cell lines
    Gupta, M.
    Barnes, D.
    Losos, J.
    Spehar, G.
    Bednarcik, M.
    Peters, W. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line
    Ying-Ying Lu
    World Journal of Gastroenterology, 2008, (35) : 5403 - 5411
  • [4] Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line
    Lu, Ying-Ying
    Jing, Da-Dao
    Xu, Ming
    Wu, Kai
    Wang, Xing-Peng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (35) : 5403 - 5411
  • [5] Motexafin gadolinium synergizes with anti-tumor agents docetaxel, pemetrexed and erlotinib in lung cancer cell lines and mouse xenograft tumors
    Naumovski, Louie
    Sirisawad, Mint
    Chen, Jun
    Thiemann, Patti
    Boswell, Garry
    Magda, Darren
    Miller, Richard
    CANCER RESEARCH, 2006, 66 (08)
  • [6] Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines
    Zhang, Wei
    Peyton, Michael
    Xie, Yang
    Soh, Junichi
    Minna, John D.
    Gazdar, Adi F.
    Frenkel, Eugene P.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (02) : 161 - 166
  • [7] Enhanced anti-tumor activity of erlotinib in combination with FAK tyrosine kinase inhibitors in non-small cell lung cancer
    Howe, Grant A.
    Xiao, Bin
    Zhao, Huijun
    Goss, Glenwood
    Addison, Christina L.
    CANCER RESEARCH, 2014, 74 (19)
  • [8] Enhanced anti-tumor activity of erlotinib in combination with FAK tyrosine kinase inhibitors in non-small cell lung cancer
    Howe, G. A.
    Xiao, B.
    Zhao, H.
    Al-Zahrani, K. N.
    Hasim, M. S.
    Villeneuve, J.
    Sekhon, H. S.
    Goss, G. D.
    Sabourin, L. A.
    Dimitroulakos, J.
    Addison, C. L.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2014, 34 : S16 - S16
  • [9] Superior anti-tumor immune response of dendritic cells fused with prostate cancer cell lines compared with tumor lysate-pulsed dendritic cells
    Lee, SB
    Lee, JM
    Jun, SY
    Yoo, C
    Song, SH
    JOURNAL OF UROLOGY, 2006, 175 (04): : 143 - 143
  • [10] Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model
    Nguyen, Cao Minh
    Vu, Trung T.
    Nguyen, Minh Nguyen
    Tran-Nguyen, Thao-Suong
    Huynh, Chi Thien
    Ha, Quang Thanh
    Nguyen, Hoai-Nghia
    Tran, Le Son
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
12345